Document is current

Article History

Received: 6 August 2019

Accepted: 9 October 2019

First Online: 28 November 2019

Ethics approval and consent to participate

: The project has been approved by the Melbourne Health Human Research and Ethics Committee (HREC 2017.145). Written informed consent is obtained from all participants and where the participant is under the age of 18 years, consent is also sought from the parent or legal guardian.

: Not applicable

: SC is funded by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1136344). MB is supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship (APP1059660 and APP1156072). KA is funded by a NHMRC Career Development Fellowship (APP1141207). CB is supported by an Alfred Deakin Postdoctoral Research Fellowship. OMD is a R.D. Wright Biomedical NHMRC Career Development Fellow (APP 1145634) and has received grant support from the Brain and Behavior Foundation, Simons Autism Foundation, Stanley Medical Research Institute, Deakin University, Lilly, NHMRC, ASBDD/Servier, and in kind support from BioMedica Nutraceuticals, NutritionCare and Bioceuticals. GPA is supported by a NHMRC Senior Research Fellowship (APP1080963). PDM is supported by a NHMRC Senior Principal Research Fellow (APP1155508). BOD is supported by a NHMRC Early Career Fellowship (APP1142045). AR is supported by a NHMRC Early Career Fellowship (APP1160108). SD has received grant support from the Stanley Medical Research Institute, NHMRC, Beyond Blue, ARHRF, Simons Foundation, Geelong Medical Research Foundation, Harry Windsor Foundation, Fondation FondaMental, Eli Lilly, Glaxo SmithKline, Organon, Mayne Pharma and Servier, speaker’s fees from Eli Lilly, advisory board fees from Eli Lilly and Novartis, and conference travel support from Servier.